These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11576884)

  • 1. Anemia: an early complication of chronic renal insufficiency.
    Kazmi WH; Kausz AT; Khan S; Abichandani R; Ruthazer R; Obrador GT; Pereira BJ
    Am J Kidney Dis; 2001 Oct; 38(4):803-12. PubMed ID: 11576884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate hematocrit levels of erythropoietin supplementary therapy in end-stage renal failure complicated by coronary artery disease.
    Nagao K; Tsuchihashi K; Ura N; Nakata T; Shimamoto K
    Can J Cardiol; 1997 Aug; 13(8):747-53. PubMed ID: 9284841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of dialysis and its relationship to dialysis adequacy, anemia management, and serum albumin level.
    Rocco MV; Bedinger MR; Milam R; Greer JW; McClellan WM; Frankenfield DL
    Am J Kidney Dis; 2001 Oct; 38(4):813-23. PubMed ID: 11576885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of anemia in patients with chronic kidney disease.
    McClellan W; Aronoff SL; Bolton WK; Hood S; Lorber DL; Tang KL; Tse TF; Wasserman B; Leiserowitz M
    Curr Med Res Opin; 2004 Sep; 20(9):1501-10. PubMed ID: 15383200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
    McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
    J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of iron saturation for erythropoietin responsiveness in chronic peritoneal dialysis.
    Jonnalagadda V; Bloom EJ; Raja RM
    Adv Perit Dial; 1997; 13():113-5. PubMed ID: 9360662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia.
    Keough-Ryan TM; Kiberd BA; Dipchand CS; Cox JL; Rose CL; Thompson KJ; Clase CM
    Am J Kidney Dis; 2005 Nov; 46(5):845-55. PubMed ID: 16253724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
    Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
    Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of erythropoietin in anemia after heart transplantation.
    Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ
    Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
    Fischer MA; Morris CA; Winkelmayer WC; Avorn J
    Arch Intern Med; 2007 Apr; 167(8):840-6. PubMed ID: 17452549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenging the validity of the EPO index.
    Kaysen GA; Müller HG; Ding J; Chertow GM
    Am J Kidney Dis; 2006 Jan; 47(1):166. PubMed ID: 16377397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infusion of total dose iron versus oral iron supplementation in ambulatory peritoneal dialysis patients: a prospective, cross-over trial.
    Ahsan N
    Adv Perit Dial; 2000; 16():80-4. PubMed ID: 11045266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anemia in chronic renal insufficiency].
    Heilmann E
    Fortschr Med; 1975 Dec; 93(34):1718-20. PubMed ID: 1193526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ITDI is the preferred treatment for iron supplementation in rHuEpo-treated anemic PD patients.
    Ahsan N
    Adv Perit Dial; 1998; 14():228-31. PubMed ID: 10649730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new rHuEPO alpha (epotin) in the management of anemia of end-stage renal disease in patients on maintenance hemodialysis.
    Abbas EE; Afioni N; Al Wakeel J; Bakr MA; Dham R; Donia A; Droubi N; Khidir E; Mathew CM; Mitwali AH; Naga S; Pingle A; Rashed A; Roshdy A; Shaheen F; Shaibani B; Shaibani FM; Shaker DS; Sheiban A; Solieman M
    Transplant Proc; 2004; 36(6):1805-11. PubMed ID: 15350482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.